COVID-19 has created deep shocks to the global environment and pushed life sciences companies to transform their supply chains and quality processes in new ways. What is the better, ‘new normal’ for quality and how are companies pivoting to create a stronger ecosystem post-crisis?
- A call to action: the need for life science organizations to build capabilities, invest, and change for the 'better, new normal'
- What is quality’s role in enabling rapid response and building resilience into the global supply chain?
- What strategic bets are companies making now to emerge stronger from the crisis?
Watch Now
* Your information is safe with us. We hate SPAM too.